Weili Tang
- Molecular Biology
- Endocrinology, Diabetes and Metabolism top 5%
- Surgery
- Cardiology and Cardiovascular Medicine
- Epidemiology
- Topics
- Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers)Adipokines, Inflammation, and Metabolic Diseases (3 papers)Diabetes and associated disorders (3 papers)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Weili Tang
17 papers receiving 529 citations
Peers
Comparison fields: 5 of 77
- Molecular Biology 296
- Endocrinology, Diabetes and Metabolism 233
- Surgery 121
- Cardiology and Cardiovascular Medicine 73
- Epidemiology 67
Countries citing papers authored by Weili Tang
This map shows the geographic impact of Weili Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weili Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weili Tang more than expected).
Fields of papers citing papers by Weili Tang
This network shows the impact of papers produced by Weili Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weili Tang. The network helps show where Weili Tang may publish in the future.
Co-authorship network of co-authors of Weili Tang
This figure shows the co-authorship network connecting the top 25 collaborators of Weili Tang. A scholar is included among the top collaborators of Weili Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weili Tang. Weili Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 9 | |
| 3 | 10 | |
| 4 | 9 | |
| 5 | 11 | |
| 6 | 61 | |
| 7 | 54 | |
| 8 | 277 | |
| 9 | Hypoadiponectinemia predicts impaired endothelium-independent vasodilation in newly diagnosed type 2 diabetic patients: an 8-year prospective study. | 14 |
| 10 | [The effect and mechanism of transient continuous subcutaneous insulin infusion therapy on beta cell function, insulin resistance and vascular endothelial injury in newly diagnosed type 2 diabetes]. | 1 |
| 11 | [Relationship of adipocyte fatty acid-binding protein to adiponectin ratio with femoral intima-media thickness and endothelium-dependent vasodilation in patients with newly-diagnosed type 2 diabetes mellitus]. | 9 |
| 12 | 2 | |
| 13 | [Decrease of FOXP3 mRNA in CD4+ T cells in latent autoimmune diabetes in adult]. | 3 |
| 14 | [Comparison of 3 working definitions of metabolic syndrome in male medical examinees]. | 3 |
| 15 | [Effects of glimepiride and metformin on free fatty acid in patients with Type 2 diabetes mellitus]. | 6 |
| 16 | [Relationship between Ala98Val variant of hepatocyte nuclear factor-1 alpha gene and late-onset type 2 diabetes in Han nationality]. | 1 |
| 17 | 69 |
About Weili Tang
Weili Tang is a scholar working on Endocrinology, Diabetes and Metabolism, Orthopedics and Sports Medicine and Genetics, having authored 17 papers that have together received 544 indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers), Adipokines, Inflammation, and Metabolic Diseases (3 papers) and Diabetes and associated disorders (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (233 citations), Orthopedics and Sports Medicine (61 citations) and Molecular Biology (296 citations). Weili Tang has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Zhiguang Zhou, Yang Xiao, Aimin Xu, Dong Yan, Dajin Zou, WU Guo-ting, Jiajun Zhao, Shenghan Lai, Jie Hong and Weifeng Shen. Their work appears in journals such as PLoS ONE, Diabetes Care and Osteoporosis International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.